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Abstract Factor Xa (FXa) is an important serine protease in the 
blood coagulation cascade. Small synthetic ompetitive inhibitors 
of FXa are under development as potential anticoagulants. To 
better understand FXa structural features and molecular ecogni- 
tion mechanisms, we have constructed three dimensional models 
of FXa-inhibitor complex structures via a new search approach 
that samples conformational space and binding space simultane- 
ously for DABE and DX-9065a, two bis amidinoaryl derivatives 
that are among the most potent and selective FXa inhibitors 
reported to date. We find the most probable binding modes for 
the two inhibitors to be a folded conformation, with one distal 
amidino group extending into the S1 pocket, forming a salt-bridge 
~ith FXa Asp-189, and the other positively charged group fitting 
into the $4 subsite, and stabilized by a cation-~r interaction. We 
propose as a hypothesis that the cavity-like $4 subsite formed by 
the three ~r-faces of the aromatic residues Tyr-99, Phe-174 and 
Trp-215 is sufficiently rich in ~r electrons that it is not only a 
hydrophobic pocket, but also forms a cation recognition site. This 
proposed cation-~r binding mechanism is one of the first proposed 
for enzymatic molecular ecognition, and for which experimental 
verification can be obtained without any complicating charge 
compensation mechanism. Our models provide plausible explana- 
tions of the structure-activity relationships observed for these 
inhibitors, and suggest hat cation-lr interactions may provide a 
novel mechanism for molecular recognition. 
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1. Introduction 
Factor Xa (FXa) is a key enzyme involved in the blood 
coagulation process, whose major function is to convert 
prothrombin to thrombin via specific proteolysis. Due to its 
central position linking the intrinsic and extrinsic activation 
mechanisms in the cascade-like coagulation pathway, inhibi- 
tion of FXa should be highly effective in controlling the clotting 
process [1-6]. A series of synthetic FXa inhibitors has been 
investigated [1,7]. However, none of them have been developed 
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Abbreviations. FXa, Factor Xa; DABE, 1,2-di-(5-amidino-2-benzofu- 
ranyl) ethane; DX-9065a, (2S)-2-[4-[[(3S)-l-acetimidoyl-3-pyrrolid- 
inyl]oxy]phenyl]-3-(7-amidino-2-naphthyl) propanoic acid; DEGR, 
dansyl-Glu-Gly-Arg chloromethyl ketone; dansyl, 1,5-N-dimethylami- 
nonaphtylsulfonyl; BPTI, bovine pancreatic trypsin inhibitor. 
as a therapeutic anticoagulant. The lack of a detailed structural 
understanding of FXa molecular ecognition may hinder fur- 
ther progress on FXa inhibitor design. Recently the crystal 
structure of FXa has been determined at2 A resolution, provid- 
ing the three dimensional structure at an atomic level, but 
crystallization of its complex with the inhibitor DEGR (dansyl- 
Glu-Gly-Arg chloromethyl ketone) was unsuccessful due to the 
intermolecular ssociation between the C terminal of one FXa 
molecule and the active site of a crystallographically neighbor- 
ing molecule [8]. Thus, computer modeling of inhibitor binding 
to FXa would be a useful alternative approach to provide 
insight into the detailed interactions between FXa and its inhib- 
itors and the structure-function relationship of the FXa active 
site. To address this issue, we have constructed three dimen- 
sional models of the inhibited FXa complex with DABE [1] 
(inhibitor '2' in Table 1) and DX-9065a [7] (inhibitor '4' in 
Table 1), two of the most potent and selective FXa inhibitors 
in the bis amidinoaryl compound series. The proposed model 
substantially explains the structure-activity relationships and 
specificity of these inhibitors. 
2. Methods 
Calculations were carried out using the MacroModel/ 
BatchMin program, Version 3.1 [9] employing the MM2 force 
field on truncated DABE and DX-9065a models with the distal 
amidino groups removed ue to their limited influence on the 
overall conformation and to their low quality parameters in the 
force field. 5000 systematic pseudo Monte Carlo searches fol- 
lowed by 500 iterations of conjugate gradient energy minimiza- 
tion were conducted both in vacuo and in a pseudo-aqueous 
environment using the volume based continuum solvation 
model [10]. The conformers generated within a 10 kcal/mol 
energetic window from that of the lowest energy conformer 
were collected with the amidino groups added back. About 30 
conformers were found for DABE, and docking into the FXa 
active site was attempted for each. About 1000 conformers were 
collected for DX-9065a; further energy minimization removed 
some duplicates, but still resulted in more than 100 conformers 
within a 2.5 kcal/mol energy window, which is too many for 
manually docking into the FXa active site. To solve this prob- 
lem, we developed a new search method for flexible molecules, 
i.e. systematic onformational search within the active site, 
which is described below. 
For this approach, the starting structures of DABE and 
DX-9065a were energy minimized with standard bond lengths 
and angles. Systematic searches were carried out using the 
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Fig. 1. Superposition of representative binding conformers of DABE (thick line) and DX-9065a (dotted line) in the FXa active site. 
Biosym program Search_Compare. Since the S1 pocket of the 
arginine- and lysine-directed serine proteases i well known to 
be responsible for the recognition of the cationic group, we 
rationalized that one of the positively charged amidino groups 
in these inhibitors extends into the S 1 pocket, forming a salt- 
bridge with the FXa Asp-189. The X-ray crystal structure of 
benzamidine complexed with thrombin [11] was thus used as a 
template to position the distal amidino group of DABE and 
DX-9065a in the S1 site of FXa by superimposing the active site 
residues of the two homologous enzymes first and then overlay- 
ing the amidinophenyl ring of the inhibitors to the benzamidine 
ring. Systematic conformational searches were first performed 
on the freely rotatable bonds of the inhibitors, with each torsion 
angle incremented in steps of 60 °, and the van der Waals radii 
scaled at 0.95. The conformers generated within a 10.0 kcal/mol 
energetic window from the lowest energy minimum for both 
inhibitors were collected within the active site, and examined 
for their steric fit by applying the 'bump_check' utility and 
intermolecular energy evaluation in INSIGHT II (Biosym 
Technologies Inc.). Conformers with the second amidinoaryl 
group out of protein surface or having collisions with FXa were 
considered less probable and discarded, while those having the 
second amidinoaryl group complementary to the FXa surface 
cleft with much lower intermolecular energies were saved. The 
geometrical distance maps and torsional angles were calculated 
for the saved conformers, and used as constraints for searches 
with smaller torsional increments of 30 ° , and then the con- 
straints obtained from the 30 ° increment searches were used for 
further 15 ° increment torsional searches. About 300 lower en- 
ergy complexes have been explored. The final conformers, with 
optimal steric fit in FXa, and within a 5.0 kcal/mol energy 
window from the lowest internal energy conformer, were sub- 
jected to energy minimization within the FXa active site using 
the DISCOVER simulation program and the corresponding 
generalized CVFF force field parameters [12]. 
The intermolecular energies, including van der Waals and 
electrostatic energies between FXa and each potentially bound 
conformer of the inhibitors, were calculated using the EVALU- 
ATE facility in the INSIGHT II program. 
3. Results 
FXa is a trypsin-like serine protease, which recognizes a basic 
residue in position P1 of its substrates by forming a salt-bridge 
between a basic residue of the substrates and the acidic residue 
Asp-189 at the bottom of the S1 pocket (Fig. 1). The residues 
Trp-215, Phe-174 and Tyr-99 form an open pocket, corre- 
sponding to the 'aryl binding site' in thrombin [13]. Here we 
refer to it as the $4 pocket, as it was modeled to accommodate 
the fourth residue, Ile (P4) from the cleavage site of its natural 
substrate, prothrombin [14]. The dansyl ring of the FXa inhib- 
itor DEGR has also been modeled to fit into this subsite by [8]. 
Systematic searches of the free torsional angles of the two 
inhibitors within the FXA acitve site optimized the location of 
the other amidino group of DABE and the pyrrolidinyl group 
of DX-9065a into the surface cleft, the $4 pocket, due to the 
lower intermolecular energy (Fig. 1). The other conformers 
with the second amidino group or the pyrrolidinyl group collid- 
ing with FXa residues or pointing into the solvent are less 
energetically favored. Table 1 shows the structures of the amid- 
inoaryl derivatives and their inhibitory activities for FXa. Re- 
moval of the second amidinobenzofuran from DABE results in 
a remarkable reduction in potency [1], clearly supporting a
model in which the second amidinoaryl moiety interacts with 
FXa instead of going into the solvent. DX-9065a has two basic 
moieties, amidinoaryl and pyrrolidinyl groups, that can both 
potentially interact with Asp- 189 of FXa, but the planar shape 
of the S1 pocket of FXa has a preference for binding to amid- 
inoaryl groups with a flat structure over the pyrrolidine [15]. 
After the potential binding region of the second amidino group 
or the pyrrolidinyl group was located, subsequent systematic 
searches with smaller torsional increments were carried out to 
fine tune the orientation of these groups in that binding region. 
The criteria for determining the potential binding modes from 
the saved conformers were first, that the complexes should have 
lower intermolecular energies, and then that the internal con- 
formational energies for the inhibitors themselves should be 
lower, since the inhibitors are quite flexible, and the effect of 
inhibitor internal energy on the binding conformation is much 
less than that of intermolecular energy. 
Fig. 1 displays the most probable binding mode of DABE 
and DX-9065a in the FXa active site. The proposed conforma- 
tion of DABE, shown in thick line in Fig. 1, compared with 
other possible binding modes (not shown in Fig. 1) which differ 
slightly in the orientations of the second amidino group, has 
more favorable interactions with FXa as suggested by the inter- 
molecular energy calculations. It also has lower intramolecular 
strain as determined by the Monte Carlo conformation search. 
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Fig. 2. Docking the proposed FXa binding conformers of DABE (thick line) and DX-9065a (dotted line) within the thrombin active site. 
Besides the obvious salt-bridge formation in the S1 pocket, 
which is an important feature common to all benzamidine- 
based serine protease inhibitors, DABE might exhibit addi- 
tional hydrogen bonding between the furan oxygen and the 
Ser-195 OH of FXa. This hydrogen bond would account for the 
observed reduction in the inhibitory activity of inhibitor '3' 
(Table 1), in which the benzimidazole has replaced the benzofu- 
ran of DABE [11]. This replacement should not significantly 
affect its conformational properties but would affect the ring 
charge distribution. Since either of the imidazole nitrogens can 
bond a hydrogen due to the tautomeric feature of the imidazole, 
neither of them would be as good as the oxygen in the furan 
as a hydrogen acceptor to interact with Set-195 OH, assuming 
that inhibitor '3' binds to FXa in the same mode as DABE. In 
Fig. 1, the second benzofuranyl group of DABE crosses over 
the extended FXa backbone segment Trp-215-Gly-216, direct- 
ing the distal amidino group into the $4 pocket formed by the 
three aromatic residues. The positively charged amidino group 
makes close contacts with the aromatic ring faces, with closest 
distances of 3.0 ~, 3.1 A and 3.4 A to the Trp-215, Phe- 174 and 
Tyr-99 rings, respectively. The absence of any anionic residues 
around the $4 subsite rules out possible charge-charge stabili- 
zation of the amidino group by FXa. These findings led us to 
postulate that the basic amidino group is stabilized via a specific 
'cation-~z interaction' [16], which is essentially an attraction of 
a positive charge to the ~r-electrons of an aromatic ring, also 
called an 'ion-quadrupole' attraction [17,18]. The cation-~ in- 
teraction is particularly effective when the aromatic system 
contains electron-rich residues like Tyr and Trp [16], especially 
when several such aromatic rings are spatially arranged in a 
pocket-like subsite, with all the ~-faces of the aromatic rings 
facing toward the center of the pocket [19]. Since the $4 subsite 
of FXa possesses both of these features, the effects of the 
cation-~z interaction should be substantial. Although at present 
there is no molecular mechanics function formulated to evalu- 
ate the magnitude of this interaction, its contribution to binding 
affinity to the synthetic host receptors has been demonstrated 
to be significant on the basis of experimental findings [20-22] 
and theoretical calculations [16,23 26]. If the cation-~r interac- 
tion is taken into consideration, this conformation of DABE 
should have the most favorable intermolecular interactions 
with FXa as a result of the optimal position of the amidino 
group in the $4 pocket with the amidino hydrogens pointing 
directly to the ~z-face of Phe-174. The close face-to-face contact 
of the amidino group and the Trp-215 indole ring would also 
give rise to so called '~-stacking' interactions. 
Compared to DABE, DX-9065a is more flexible due to two 
additional freely rotatable bonds. Although the orientation of 
the DX-9065a pyrrolidine ring is less defined, all possible orien- 
tations confine a volume that fills the $4 subsite and generates 
favorable hydrophobic interactions with the three aromatic 
residues in the $4 subsite (not shown in Fig. 1). Of the possible 
binding conformers, the one shown in the dotted line in Fig. 1 
was chosen as representative, since it has the most favorable 
VDW interactions with FXa, as well as the strongest cation-~ 
interaction due to the closest contact of the pyrrolidine moiety 
to the ring faces of Phe-174 and Trp-215 in the $4. It is also the 
least conformationally strained structure among all the poten- 
tially bound conformations, and was found in the Monte Carlo 
searches to be a relatively stable local minimum structure. Be- 
sides the salt-bridge interaction in the S1 site, the carboxylate 
group of DX-9065a has close contact with the guanidinyl group 
of the FXa Arg-143. The positively charged acetimidoyl moiety 
surrounded by the three aromatic walls is strongly stabilized via 
the cation-~ interactions mentioned above. The cation-~ inter- 
action provides an explanation of the activity difference be- 
tween inhibitors '4' and '5' listed in Table 1. The modification 
of the pyrrolidine in '4' to an amidino type moiety in DX-9065a 
leads to an increased basicity of the cation due to electron 
delocalization, and thus enhances the cation-~ interaction in 
the $4 subsite. Furthermore, it has been rationalized that 
weaker binding of protonated amines like N H4 + to the aromatic 
host over alkylated amines is due to their larger desolvation 
penalty upon binding than the alkylated amines [27]. Compared 
to the pyrrolidine group, the additional methyl group of the 
acetimidoyl moiety not only increases hydrophobic nteractions 
with the FXa $4 subsite, but also decreases the desolvation 
energy cost. 
Superposition of the proposed DABE and DX-9065a bound 
mode, as shown in Fig. 1, demonstrated essentially similar 
folded conformations for the two inhibitors. The major forces 
for binding are common to both, i.e. the salt-bridge formation 
in the S1 subsite and the cation-~ interaction in the $4 subsite. 
Both inhibitors, especially DX-9065a, are selective for FXa 
compared to thrombin (Table 1). We docked the proposed 
bound structures of the two inhibitors into the active site of 
thrombin by superimposing the active sites of the two enzymes 
(Fig. 2). However, binding to thrombin would be energetically 
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disfavored ue to strong interference between the amidino or 
acetimidoyl group of the inhibitors and thrombin Ile-174. These 
two inhibitors are sufficiently flexible that we cannot rule out 
possible conformational djustments to avoid collision with 
Ile-174. However, the cationqr interaction is definitely absent 
in the corresponding thrombin 'aryl binding site' since it is 
formed by only one aromatic residue, Trp-215, and the two 
aliphatic residues Leu-99 and Ile-174, which cannot provide 
sufficient ~r electrons to stabilize the cation. The particularly 
poor affinity of DX-9065a with thrombin is probably due to 
additional charge-charge r pulsion between the carboxylate 
group in DX-9065a nd the Glu-192 side chain in thrombin [15] 
(see Fig. 2), while in FXa, position 192 has a neutral Gln 
residue, and the DX-9065a carboxylate group is stabilized by 
the nearby Arg-143 (Fig. 1). 
4. Discussion and conclusions 
A complete conformational space search of flexible mole- 
cules, as well as their docking into a specific binding region is 
always complicated by the large number of possible conform- 
ers. To reduce the size of this problem, we developed a new 
search approach to construct he possible binding modes. 
Based on the rationale that one of the positively charged amid- 
ino groups in these inhibitors extends into the S1 pocket, since 
the S1 pocket of the arginine- and lysine-directed serine pro- 
teases is well known to be responsible for recognition of the 
cationic group, we fixed one of the amidino aryl groups in the 
S1 pocket, and started from a search of the entire conforma- 
tional space of the inhibitors inside the FXa active site with 
relatively coarse torsional increments to locate the potential 
bound conformational region, and then conducted further in- 
tensive searches focused on this region. Our strategy was thus 
to combine conformational searching and binding mode 
searching into one process to eliminate unnecessary efforts in 
conformational space other than the potential bound confor- 
mation region, thus also eliminating a complex docking analy- 
sis. 
The resultant modes show that both inhibitors DABE and 
DX-9065a adopt a folded conformation, with one amidino 
group extending into the S1 subsite and the other fitting into 
the $4 pocket. Although conformational searches of both in- 
hibitors revealed that the extended conformation is most ener- 
getically favorable, consistent with the X-ray crystal structures 
[7], the flexibility of these inhibitors allows diverse conforma- 
tions within a small energy difference. Moreover, induced fit 
effects from the enzyme should be large enough to compensate 
for the conformational energy loss. The internal energy of our 
proposed bound conformation was only about 2.0 kcal/mol 
higher than that of the lowest energy conformers found in the 
searches (not including binding interactions). Although the pre- 
cise atomic location of the inhibitors inside the FXa need to be 
refined by crystallographic studies, the general binding interac- 
tions with S1 and $4 sites proposed by modeling should be 
plausible. 
The most important findings of this study are first, the iden- 
tification of a potential cation-~r recognition site formed by the 
three aromatic residues Trp-215, Tyr-99 and Phe-173 within the 
FXa active site, and second, the clarification of the special 
molecular recognition mechanism of FXa toward the bis amid- 
inoaryl derivatives. Recently the cation-Tr interaction has re- 
ceived considerable attention as a new type of binding interac- 
tion. Besides the extensive investigations on artificial host-guest 
systems [16,18,27-30], computational studies of several biolog- 
Table 1. Structures of synthetic nhibitors and their inhibitory activities toward FXa and thrombin 
Inhibitors Ki, ~'n a iC50 ' i.tm b 
No. Structure FXa Thrombin FXa Thrombin 
° (Am- -<)  169 123 
Am ~ ~ M - -  ~ " ~ A  m 0.573 14.9 
Am"~"~ N H 
 9.o 
~ v ~  c°2n 
Am ND ND 
o Nil 
ND a ND 
0.10 5 
ND 
0.31 
ND 
>600 
0.07 > 2000 
"Ki: dissociation constants of the enzyme-inhibitor complexes from TidweU et a1.(1980). 
b IC.50: concentrations eeded for inhibiting enzymes by 50% from Nagahara et a1.(1994). 
c ND: no experimental data 
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ical systems have postulated an important role in molecular 
recognition for such systems as ion selectivity of the potassium 
channel [31], binding of acetylcholine to acetylcholinesterase 
[16,32], and binding of choline derivatives to phospholipases A 2
[33]. The most direct evidence for biological importance has 
been the X-ray crystallographic determination f such an inter- 
action in the immunoglobulin Fab McPC603-phosphocholine 
complex [34]. However, in most cases, the presence of ionic 
residues near the cation binding site complicates interpretation 
of the role of cation-n interactions, ince charge-charge inter- 
actions are long range electrostatic effects [16,32,35]. Our 
conformational analysis of FXa complexes with amidinoaryl deriv- 
atives provides a clear and verifiable hypothesis for the impor- 
tance of cation-~ interactions in molecular ecognition. The 
FXa $4 subsite shares very similar architectural features with 
the Fab McPC603 antibody binding site, i.e. three aromatic 
rings arranged with two of them facing each other, edge to face 
with the third one. This forms a box-like cavity perfect to 
accommodate a cation like an amidino group. The absence of 
any acidic residue around the $4 subsite in FXa should estab- 
lish the exclusive role of the cation-g interaction in molecular 
recognition. It is well known that the $4 subsite is quite hydro- 
phobic and prefers to bind hydrophobic groups, such as the 
naphthyl ring of DEGR [8], the IleP4 of prothrombin [14] or 
the Pro of BPTI [8]. This does not contradict i s cation recogni- 
tion function. Actually, the $4 pocket of FXa should possess 
dual functionality, with its selectivity depending on the incom- 
ing ligand. This also explains its preference for a hydrophobic 
cation with high basicity, but low desolvation energy. We be- 
lieve that this model is a better mechanism for molecular recog- 
nition than the model proposed by Katakura et al. [15] in which 
the acetimidoyl of DX-9065a is oriented out of the $4 pocket. 
That model cannot provide a plausible xplanation of the effect 
of the basicity of a second charged group on inhibitory affinity. 
Our model proposes the involvement of the cation-n interac- 
tion in FXa molecular ecognition, identifies the active mode 
of the structural elements with the FXa active site, and provides 
a sound explanation of FXa's selectivity toward the bis amidi- 
noaryl compounds. This cation recognition should be unique 
to FXa. In thrombin, the corresponding pocket, known as the 
'aryl binding site' is also hydrophobic, but would not be a 
cation recognition site, as it is formed by one aromatic Trp-215 
and two aliphatic residues, Leu-99 and Ile-174, and it is not zr 
electron rich enough to attract a cation. Trypsin and chymot- 
rypsin also would not accept a cation in their corresponding 
sites for the same reason. 
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